⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BDTX News
Black Diamond Therapeutics, Inc. Common Stock
Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
prnewswire.com
AZN
BDTX
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
BDTX
Form 8-K
sec.gov
BDTX
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
BDTX
Form 8-K
sec.gov
BDTX
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
globenewswire.com
BDTX
Form 8-K
sec.gov
BDTX
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
globenewswire.com
BDTX
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
globenewswire.com
BDTX
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
BDTX